Hearing 4589 for Sahota, Jaspreet

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Jaspreet Sahota, between in or about October 2021 and in or about June 2025, while engaged in the practice of pharmacy as owner, director, shareholder, Designated Manager, and/or pharmacist at Fort William Medical Pharmacy in Thunder Bay, Ontario, committed professional misconduct in that he engaged in (or permitted, consented to, or approved, expressly or by implication) the following conduct:

• Dispensing, selling by retail, and/or delivering drugs to patients and/or persons in the United States, including:
  • in a manner contrary to the College’s Cross-Jurisdictional Pharmacy Services Policy;
  • without a lawful and/or valid prescription;
  • on the basis of co-signed and/or re-written prescriptions and/or prescriptions where the prescriber did not have an existing therapeutic relationship with the patients and/or persons;
  • without taking reasonable steps to confirm the validity of prescriptions and/or whether the prescriber had an established therapeutic relationship with the patients and/or persons;
  • in a manner that did not protect the cold chain and/or did not allow for temperature monitoring or recording of temperatures for drugs and/or products requiring refrigeration;
  • where the drug was delivered to persons other than the patient and/or their authorized agent; and/or
  • without maintaining adequate and/or accurate records. 
• Returning to stock, re-selling, and/or re-dispensing a drug that was previously sold or dispensed where the drug required refrigeration;
• Submitting claims for drugs and/or products that were never prescribed and/or dispensed for one or more of certain identified drugs and/or products;
• Falsifying records relating to one or more of certain identified drugs and/or products;
• Failing to keep records and/or documentation as required for one or more of certain identified drugs and/or products; 
• Providing unregulated staff and/or persons with remote access to the Pharmacy’s records and/or computer systems in a manner that did not maintain patient privacy and/or allow for supervision;
• Providing his login credentials and/or the login credentials of other pharmacists for the Pharmacy’s computer systems to unregulated staff and/or persons;
• Instructing unregulated staff and/or persons to falsify records, submit false and/or misleading claims, and/or process prescriptions as dispensed and/or clinically verified with his login credentials and/or the login credentials of other pharmacists; and/or  
• Failing to exercise appropriate oversight of the Pharmacy.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to (or permitted, consented to, or approved, expressly or by implication, the failure to) keep records as required respecting his patients and/or practice;
• Falsified (or permitted, consented to, or approved, expressly or by implication, the falsification of) a record relating to his practice and/or a person’s health record;
• Signed and/or issued (or permitted, consented to, or approved, expressly or by implication, the signing and/or issuance of), in his professional capacity, a document that he knew or ought to have known contained a false and/or misleading statement;
• Submitted (or permitted, consented to, or approved, expressly or by implication, the submission of) an account and/or charge for services and/or products that he knew or ought to have known was false and/or misleading;
• Contravened (or permitted, consented to, or approved, expressly or by implication, the contravention of):
  • sections 152, 155, 156, 163, and/or 166 of the Drug and Pharmacies Regulation Act and/or
  • sections 18, 19 and/or 20 of Ontario Regulation 264/16;
• Contravened (or permitted, consented to, or approved, expressly or by implication, the contravention of) sections C.01.041 and/or C.01.042 of the Food and Drug Regulations;
• Returned to stock, resold, or re-dispensed (or permitted, consented to, or approved, expressly or by implication, the return, reselling, or re-dispensing of) a drug that was previously sold or dispensed;
• Permitted, consented to, approved, counselled, and/or assisted, whether expressly or by implication, the commission of an offence against any Act relating to the practice of pharmacy or the sale of drugs, including:
  • sections 152, 155, 156, 163, 165, and/or 166 of the Drug and Pharmacies Regulation Act;
  • sections 18, 19 and/or 20 of Ontario Regulation 264/16;
  • section 31 of the Food and Drugs Act; and/or
  • sections C.01.041 and C.01.042 of the Food and Drug Regulations;
• Engaged in conduct or performed (or permitted, consented to, or approved, expressly or by implication) an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and/or unprofessional.